Skip to main content
Premium Trial:

Request an Annual Quote

Georg Casari, Edward Fritsch, Albert Collinson

Premium

Cellzome has appointed Georg Casari to the position of vice president for informatics, the Heidelberg, Germany-based company said last week. Casari, a co-founder of Lion Bioscience, served as senior vice president and head of life science research for Lion prior to joining Cellzome. Before helping found Lion, Casari was a staff scientist at the European Molecular Biology Laboratory and the European Bioinformatics Institute, working in the area of high-throughput sequence analysis.

 

Edward Fritsch has joined Phylos as senior vice president of development, the Lexington, Mass.-based developer of affinity-binding proteins said last week. Fritsch will be responsible for developing biopharmaceuticals based on Phylos’ platform technology, the company said. Prior to joining Phylos, Fritsch spent 19 years at the Genetics Institute, a subsidiary of Wyeth Research, where he served as a senior scientist, vice president of research, vice president of process and product development, and vice president of development management. During his last two years with the Genetics Institute, he was responsible for overall project management of all protein development projects. Separately, Phylos said it has promoted Albert Collinson to senior vice president for business development, from vice president for business development.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.